(2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide

C25H26F3N3O3 — CID 159552877

IUPAC(2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide
SMILESCC[C@@H](C(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2CC1=O)[C@H](CCC(F)(F)F)C(N)=O
InChIInChI=1S/C25H26F3N3O3/c1-2-17(19(22(29)33)12-13-25(26,27)28)24(34)31-23-20(32)14-16-10-6-7-11-18(16)21(30-23)15-8-4-3-5-9-15/h3-11,17,19,23H,2,12-14H2,1H3,(H2,29,33)(H,31,34)/t17-,19+,23-/m1/s1
InChIKeyWLAOIUGOSJSUGL-HFJQGTKSSA-N
MW473.50 g/mol
LogP3.56
Rot. Bonds8

About (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide

(2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide (PubChem CID 159552877) has the molecular formula C25H26F3N3O3 and a molecular weight of 473.50 g/mol. Its IUPAC name is (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide.

Molecular Properties

Compound Name(2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide
PubChem CID159552877
Molecular FormulaC25H26F3N3O3
Molecular Weight473.50 g/mol
Exact Mass473.19
IUPAC Name(2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide
SMILESCC[C@@H](C(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2CC1=O)[C@H](CCC(F)(F)F)C(N)=O
InChIInChI=1S/C25H26F3N3O3/c1-2-17(19(22(29)33)12-13-25(26,27)28)24(34)31-23-20(32)14-16-10-6-7-11-18(16)21(30-23)15-8-4-3-5-9-15/h3-11,17,19,23H,2,12-14H2,1H3,(H2,29,33)(H,31,34)/t17-,19+,23-/m1/s1
InChIKeyWLAOIUGOSJSUGL-HFJQGTKSSA-N
XLogP3.56
TPSA101.62 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500473.50
LogP ≤ 53.56
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide?
The IUPAC name of (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide (CID 159552877) is (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide.
What is the SMILES notation for (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide?
The canonical SMILES for (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide is CC[C@@H](C(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2CC1=O)[C@H](CCC(F)(F)F)C(N)=O.
What is the InChIKey of (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide?
The InChIKey is WLAOIUGOSJSUGL-HFJQGTKSSA-N. The full InChI is InChI=1S/C25H26F3N3O3/c1-2-17(19(22(29)33)12-13-25(26,27)28)24(34)31-23-20(32)14-16-10-6-7-11-18(16)21(30-23)15-8-4-3-5-9-15/h3-11,17,19,23H,2,12-14H2,1H3,(H2,29,33)(H,31,34)/t17-,19+,23-/m1/s1.
What are the key properties of (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide?
(2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide has a molecular weight of 473.50 g/mol, XLogP of 3.56, 8 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,3R)-3-ethyl-N'-[(3S)-4-oxo-1-phenyl-3,5-dihydro-2-benzazepin-3-yl]-2-(3,3,3-trifluoropropyl)butanediamide is sourced from PubChem (CID 159552877), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).